The role of NPM1 in human cancer has received a new spotlight with the discovery of mutations of exon 12 of NPM1 in approximately 30% of adult de novo AML, and in 50–60% in those with a normal karyotype [46,47]. The gene discussed is NPM1; the disease is acute myeloid leukemia.